In September 2023, which of the following ministries launched the National Policy on Research and Development and Innovation in the Pharma-MedTech Sector in India along with the PRIP scheme?

With reference to the BioE3 Policy, consider the following statements: I. The BioE3 Policy seeks to promote biotechnology-driven manufacturing and bio-based innovation in India. II. The policy is associated with sectors such as precision therapeutics, climate-resilient agriculture and carbon capture utilisation. III. The policy is implemented under the Ministry of Environment, Forest and Climate Change. Which of the statements given above are correct?

Consider the following statements regarding the Rajasthan Aerospace and Defence Policy announced in January 2026 and select the correct option: A. Under the policy, manufacturing projects with a capital investment between a minimum of ₹ 50 crore and ₹ 300 crore will be classified as 'Large', ₹ 300 crore to ₹ 1,000 crore as 'Mega', and above ₹ 1,000 crore as 'Ultra Mega'. B. Eligible aerospace and defence manufacturing and service units set up in A and D parks will receive investment support in the form of reimbursement of 75 percent of state taxes for seven years as an asset creation incentive.